LAS-194871

N/A

Report date: 2023/01/08 10:16:20

Base Information

Drug NameLAS-194871
Drug Alias NameLAS-194871
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonistsMuscarinic acetylcholine receptor M3 antagonists
TargetsBeta-2 adrenergic receptorMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlmirall Sa
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca PlcAlmirall Sa
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A